Gilat Demonstrates Breakthrough AI-Based Interference Detection and Cancellation Technology for Satellite Links

Stock Information for Telomir Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Telomir Pharmaceuticals Inc.

Gilat Signs $14 Million Agreement to Expand Broadband Internet Access in Peru
Gilat Reports Second Quarter 2026 Results
Gilat to Present at Upcoming Investor Conferences
Gilat to Report Second Quarter 2026 Results on Wednesday, August 5
Leading Global Satellite Operator Awards Gilat Over $20 Million in SkyEdge Orders
Gilat Receives $11 Million in U.S. Department of War Orders, Reinforcing Role in Mission-Critical Defense Connectivity
Gilat Receives $43 Million of Additional Sidewinder ESA Orders from Leading In-flight Connectivity Service Provider
Gilat Receives Multi-Million Dollar Order for Customized SATCOM Terminals Supporting European Defense Communications

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.